Ventricular Tachycardia clinical trials at UCSD
2 in progress, 0 open to eligible people
FLExAbility Sensor Enabled Substrate Targeted Ablation for the Reduction of VT Study
Sorry, in progress, not accepting new patients
This clinical investigation is intended to demonstrate the safety and effectiveness of ventricular ablation therapy using the FlexAbility Sensor Enabled Ablation Catheter in patients with drug-refractory monomorphic ventricular tachycardia in whom ventricular tachycardia recurs despite antiarrhythmic drug therapy or when antiarrhythmic drugs are not tolerated or desired.
San Diego, California and other locations
Transseptal vs Retrograde Aortic Ventricular Entry to Reduce Systemic Emboli
Sorry, in progress, not accepting new patients
This study is a prospective, multicenter, randomized (1:1) controlled comparative effectiveness trial of a transseptal approach to left ventricular ablation compared to a retrograde aortic approach to prevent cerebral emboli and neurocognitive decline in adults with ventricular tachycardia (VT) and/or premature ventricular contractions (PVCs).
San Diego, California and other locations
Last updated: